Aug 16, 00
|
| 08:30 ET |
Doros Platika, M.D. Elected to VITEX Board
|
|
Aug 04, 00
|
| 08:30 ET |
VITEX Reports Second Quarter 2000 Results
|
|
Aug 01, 00
|
| 09:04 ET |
Vitex and Red Cross Extend Transfusion Plasma Contract
|
|
Jul 10, 00
|
| 09:26 ET |
Vitex Releases New Data on INACTINE(TM)-Treated Red Cells at International Society of Blood Transfusion (ISBT) Meeting
|
|
May 31, 00
|
| 09:13 ET |
James A. Moose Joins VITEX to Lead Plasma Operations
|
|
May 15, 00
|
| 08:31 ET |
Vitex Strengthens Clinical and Regulatory Management Team
|
|
May 04, 00
|
| 08:31 ET |
V. I. Technologies (VITEX) Reports First Quarter 2000 Results
|
|
May 03, 00
|
| 08:31 ET |
Medicare Initiates Reimbursement for VITEX's PLAS+(R)SD
|
|
Apr 25, 00
|
| 11:35 ET |
Amersham Pharmacia Biotech to Market VITEX's INACTINE(TM) Technology For Biopharmaceutical, Transgenic and Plasma Fractionation Applications
|
|
Apr 24, 00
|
| 08:29 ET |
VITEX Appoints David C. Dlesk Executive Vice President, Chief Business Officer for INACTINE(TM)
|
|
Apr 04, 00
|
| 08:30 ET |
V.I. Technologies (VITEX) Initiates Pivotal Trial of Next Generation Plasma Product
|
|
Mar 27, 00
|
| 15:10 ET |
V. I. Technologies (VITEX) Announces Relocation of its Headquarters to Boston
|
|
Jan 21, 00
|
| 08:15 ET |
V. I. Technologies (VITEX) Reports Fourth Quarter Results
|
|
Jan 12, 00
|
| 08:30 ET |
VITEX Announces $65 Million Extension of Bayer Agreement
|
|
Dec 06, 99
|
| 08:15 ET |
Pall Makes $3.0 Million Milestone Investment in VITEX; Payment Triggered with Initiation of Red Blood Cell Clinical Trials
|
|
Nov 15, 99
|
| 08:05 ET |
V.I. Technologies and Pentose Pharmaceuticals Complete Merger
|
|
Oct 19, 99
|
| 14:49 ET |
V. I. Technologies, Inc. (VITEX) Reports Third Quarter Results
|
|
Sep 30, 99
|
| 17:12 ET |
American Red Cross Accelerates Conversion to Plas+(R)SD
|
|
Aug 30, 99
|
| 16:15 ET |
Vitex Files With the FDA for Expanded Safety Step in the Manufacture Of PLAS+(R)SD
|
|
Aug 12, 99
|
| 08:30 ET |
VITEX Files With the FDA to Commence Clinical Trials of New "Universal" Plasma
|
|
Aug 06, 99
|
| 17:31 ET |
American Red Cross Agreement With Novation Expands Access to VITEX'S PLAS+(R)SD
|
|
Jul 20, 99
|
| 08:02 ET |
V. I. Technologies, Inc. (VITEX) Reports Second Quarter Results
|
|
Jul 14, 99
|
| 16:15 ET |
VITEX Completes Assessment of PLAS+SD Recall
|
|
Jun 29, 99
|
| 10:08 ET |
VITEX Adds Additional Safety Step In PLAS+SD
|
|
Jun 16, 99
|
| 12:31 ET |
V.I. Technologies, Inc. (VITEX) Receives Canadian Approval for PLAS+SD
|
|
May 12, 99
|
| 08:04 ET |
VITEX Completes Voluntary Recall and Implements Additional Viral Safety Testing
|
|
Apr 20, 99
|
| 15:10 ET |
V.I. Technologies, Inc. (VITEX) Reports First Quarter Profit
|
|
Apr 16, 99
|
| 16:04 ET |
VITEX Initiates Precautionary Safety Steps and Voluntary Recall
|
|
Mar 15, 99
|
| 13:18 ET |
VITEX Announces Expanded Distribution of PLAS+(R)SD
|
|
Feb 23, 99
|
| 08:28 ET |
Vitex to Present Preclinical Data on Red Blood Cell Program At The Blood Safety and Screening Conference
|
|
Jan 19, 99
|
| 07:31 ET |
V. I. Technologies, Inc. (VITEX) Reports Fourth Quarter Profit of $1.0 Million
|
|
Dec 21, 98
|
| 07:05 ET |
Vitex Receives $50 Million Minimum Order from the American Red Cross
|
|